-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Lhd103keDLPVRB+KtsWag3NlWjm33aZ68tEaeYyHRkEW2mzMn1xW04hf2WIeQkH4 k+24mTqxYljs/D7Wbv12BA== 0001237899-09-000018.txt : 20090727 0001237899-09-000018.hdr.sgml : 20090727 20090727164305 ACCESSION NUMBER: 0001237899-09-000018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090724 FILED AS OF DATE: 20090727 DATE AS OF CHANGE: 20090727 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STAHL NEIL CENTRAL INDEX KEY: 0001226689 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 09964939 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 4 1 edgardoc.xml PRIMARY DOCUMENT X0303 4 2009-07-24 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001226689 STAHL NEIL 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 SVP Res and Dev Sciences Common Stock 2009-07-24 4 M 0 10537 9.49 A 10887 D Common Stock 2009-07-24 4 S 0 10537 20 D 350 D Common Stock 2009-07-24 4 M 0 89463 9.49 A 89813 D Common Stock 2009-07-24 4 F 0 42154 20.14 D 47659 D Common Stock 2009-07-24 4 F 0 20423 20.14 D 27236 D Common Stock 2009-07-27 4 S 0 24686 20.74 D 2550 D Common Stock 2009-07-27 4 S 0 2200 21.02 D 350 D Common Stock 4639 I By 401(k) Plan Incentive Stock Option (right to buy) 9.49 2009-07-24 4 M 0 10537 D 2014-12-15 Common Stock 10537 0 D Non-Qualified Stock Option (right to buy) 9.49 2009-07-24 4 M 0 89463 D 2014-12-15 Common Stock 89463 0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). The reporting person sold 24,686 shares of Company stock on July 27, 2009 at prices ranging from $20.56 to $20.92. Upon request by the Commission staff, the Company, or a security holder of the Company, we will provide full information regarding the number of shares sold by the reporting person on July 27, 2009 at each separate price. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case. /s/**Neil Stahl 2009-07-27 -----END PRIVACY-ENHANCED MESSAGE-----